Related Experiment Video
Updated: Jun 27, 2026
14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Recent trends in antimicrobial resistance among Streptococcus pneumoniae and Staphylococcus aureus isolates: the
Abstract:
In France, the overall proportion of penicillin-non-susceptible Streptococcus pneumoniae has decreased from 53% in 2002 to 38% in 2006, and the proportion of methicillin-resistant Staphylococcus aureus from 33% in 2001 to 26% in 2007. Although the rates remain very high compared to Northern European countries, these trends suggest that the prevention efforts implemented since 2000 are successful.
Insights
France saw a significant decrease in penicillin-non-susceptible Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus rates. These trends indicate the success of antimicrobial resistance prevention efforts implemented since 2000.
Area of Science:
- Medical microbiology
- Infectious disease epidemiology
Background:
- Antimicrobial resistance (AMR) poses a significant global health threat.
- High rates of AMR in France have been a concern, particularly for Streptococcus pneumoniae and Staphylococcus aureus.
- National prevention strategies were implemented in France starting in 2000 to combat rising AMR.
Purpose of the Study:
- To evaluate the trends in penicillin-non-susceptible Streptococcus pneumoniae (PNSP) and methicillin-resistant Staphylococcus aureus (MRSA) in France.
- To assess the effectiveness of antimicrobial resistance prevention efforts initiated in France.
Main Methods:
- Analysis of national surveillance data for Streptococcus pneumoniae and Staphylococcus aureus susceptibility patterns.
- Comparison of resistance proportions over specified time periods (2001-2007).
Main Results:
- The proportion of penicillin-non-susceptible Streptococcus pneumoniae decreased from 53% in 2002 to 38% in 2006.
- The proportion of methicillin-resistant Staphylococcus aureus decreased from 33% in 2001 to 26% in 2007.
- Despite reductions, resistance rates in France remain higher than in Northern European countries.
Conclusions:
- The observed declines in PNSP and MRSA demonstrate the positive impact of antimicrobial stewardship and infection control measures in France.
- Continued vigilance and adherence to prevention strategies are crucial to further reduce AMR and mitigate public health risks.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:31Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...